PortalPublikationenHAGIL (Hamburg Vigil Study): a randomized placebo-controlled...

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.

Standard

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. / Möller, Fabian; Poettgen, Jana; Broemel, F; Neuhaus, A; Daumer, M; Heesen, Christoph.

in: MULT SCLER J, Jahrgang 17, Nr. 8, 8, 2011, S. 1002-1009.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Möller, F, Poettgen, J, Broemel, F, Neuhaus, A, Daumer, M & Heesen, C 2011, 'HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.', MULT SCLER J, Jg. 17, Nr. 8, 8, S. 1002-1009. <http://www.ncbi.nlm.nih.gov/pubmed/21561959?dopt=Citation>

APA

Möller, F., Poettgen, J., Broemel, F., Neuhaus, A., Daumer, M., & Heesen, C. (2011). HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. MULT SCLER J, 17(8), 1002-1009. [8]. http://www.ncbi.nlm.nih.gov/pubmed/21561959?dopt=Citation

Vancouver

Möller F, Poettgen J, Broemel F, Neuhaus A, Daumer M, Heesen C. HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis. MULT SCLER J. 2011;17(8):1002-1009. 8.

Bibtex

@article{5aeba0bf49b849b8bcd940fb5c415443,
title = "HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.",
abstract = "To reassess the effect of modafinil, a wakefulness-promoting artificial psychostimulant, on fatigue and neuropsychological measures in patients with multiple sclerosis.",
keywords = "Adult, Humans, Male, Female, Double-Blind Method, Benzhydryl Compounds/*therapeutic use, Fatigue/*drug therapy/etiology, Multiple Sclerosis/complications/*drug therapy, Neuroprotective Agents/*therapeutic use, Adult, Humans, Male, Female, Double-Blind Method, Benzhydryl Compounds/*therapeutic use, Fatigue/*drug therapy/etiology, Multiple Sclerosis/complications/*drug therapy, Neuroprotective Agents/*therapeutic use",
author = "Fabian M{\"o}ller and Jana Poettgen and F Broemel and A Neuhaus and M Daumer and Christoph Heesen",
year = "2011",
language = "English",
volume = "17",
pages = "1002--1009",
journal = "MULT SCLER J",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "8",

}

RIS

TY - JOUR

T1 - HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.

AU - Möller, Fabian

AU - Poettgen, Jana

AU - Broemel, F

AU - Neuhaus, A

AU - Daumer, M

AU - Heesen, Christoph

PY - 2011

Y1 - 2011

N2 - To reassess the effect of modafinil, a wakefulness-promoting artificial psychostimulant, on fatigue and neuropsychological measures in patients with multiple sclerosis.

AB - To reassess the effect of modafinil, a wakefulness-promoting artificial psychostimulant, on fatigue and neuropsychological measures in patients with multiple sclerosis.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Double-Blind Method

KW - Benzhydryl Compounds/therapeutic use

KW - Fatigue/drug therapy/etiology

KW - Multiple Sclerosis/complications/drug therapy

KW - Neuroprotective Agents/therapeutic use

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Double-Blind Method

KW - Benzhydryl Compounds/therapeutic use

KW - Fatigue/drug therapy/etiology

KW - Multiple Sclerosis/complications/drug therapy

KW - Neuroprotective Agents/therapeutic use

M3 - SCORING: Journal article

VL - 17

SP - 1002

EP - 1009

JO - MULT SCLER J

JF - MULT SCLER J

SN - 1352-4585

IS - 8

M1 - 8

ER -